David E. Reisner, PhD, is a well-known early pioneer and entrepreneur in the burgeoning field of nanotechnology, having cofounded in 1996 two nanotech companies in Connecticut, Inframat and US Nanocorp. For nearly 15 years, he was CEO of both companies since founding, which were recognized in Y2002-Y2005 for their fast revenue growth as Deloitte & Touche Connecticut Technology Fast50 Award recipients. In 2004, The Nano Group Inc. was formed as a parent holding company for investment. Reisner and cofounders were featured in Forbes magazine in 2004.
David has more than 175 publications and is an inventor on 10 issued patents. He is the editor for the Bionanotechnology sections of both the third edition of The BioMedical Engineering Handbook (CRC Press) and the Handbook of Research on Biomedical Engineering Education and Advanced Bioengineering Learning (IGI Global). He is editor of Bionanotechnology: Global Prospects (CRC Press) and Bionanotechnology II: Global Prospects (CRC Press). He has written articles on the business of nanotechnology in Nanotechnology Law & Business as well as the Chinese publication Science & Culture Review.David served a 3-year term as a Technology Pioneer for the World Economic Forum and was a panelist at the 2004 Annual Meeting in Davos. David has served on the Board of the Connecticut Venture Group and was Chairman of the Board of the Connecticut Technology Council from 2005 to 2009. He was a NASA NanoTech Briefs Nano50 awardee in 2006. For his efforts in the field of medical implantable devices, he won the first annual BEACON award for Medical Technology in 2004. He is a member of the Connecticut Academy of Science and Engineering.
David is a 1978 University Honors graduate from Wesleyan University and received his PhD from Massachusetts Institute of Technology in 1983 in the field of chemical physics. An avid hiker, he summited Kilim